Jill Henrich
EVP, Global Head RA & Quality, Atara Biotherapeutics, Inc.
Companies
- Atara Biotherapeutics, Inc.EVP, Global Head RA & Quality Jun 9, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Atara Biotherapeutics, Inc. ATRA18,679 shares2$172.6K at $9.24Mar 3, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 3, 2025Sold 1,059 shares at $7.00 of Atara Biotherapeutics, Inc.2
- Nov 18, 2024Sold 1,000 shares at $11.20 of Atara Biotherapeutics, Inc.3
- Aug 16, 2024Sold 132 shares at $6.63 of Atara Biotherapeutics, Inc.4
- Aug 16, 2024Sold 831 shares at $6.63 of Atara Biotherapeutics, Inc.4
- May 16, 2024Sold 25,750 shares at $0.62 of Atara Biotherapeutics, Inc.5
- Mar 4, 2024Sold 3,879 shares at $0.72 of Atara Biotherapeutics, Inc.6
- Jan 8, 2024Granted 450,000 shares of Atara Biotherapeutics, Inc.7
- Nov 16, 2023Sold 3,267 shares at $0.39 of Atara Biotherapeutics, Inc.8
- Aug 16, 2023Sold 558 shares at $1.65 of Atara Biotherapeutics, Inc.9
- Aug 16, 2023Sold 2,788 shares at $1.65 of Atara Biotherapeutics, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Nov 20, 2024
- 4SEC EDGARForm 4 filed Aug 20, 2024
- 5SEC EDGARForm 4 filed May 20, 2024
- 6SEC EDGARForm 4 filed Mar 6, 2024
- 7SEC EDGARForm 4 filed Jan 9, 2024
- 8SEC EDGARForm 4 filed Nov 20, 2023
- 9SEC EDGARForm 4 filed Aug 18, 2023